28bio, Inc.

Amendment
CIK: 0001769360·Biotechnology·DELAWARE·Filed: Jan 27, 2026
Total Offering

$7,000,000

Amount Sold

$6,525,000

Investors

8

First Sale

May 21, 2025

Offering Details

Type
Equity
Exemptions
Rule 506(b)

Related Persons

NameRole
Alif Saleh
Executive Officer, Director
David Weiner
Director
Dale Pfost
Director
Michael Katz
Director
Miklos Kobor
Director

Company

28bio, Inc.

4224 HOUMA BLVD., SUITE 224

METAIRIE, LA, 70006

504-407-7419

SEC Filing

0001769360-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free